Physician profile
Caitlin Dumm
NPI 1659135101
$1,720.92
in general payments reported to CMS, 2019-2025
15 companies · $1,564 in 2025
The $1,564 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $157 · 2025: $1,564.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,621 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,620.93 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $347.46 | 2025 | Tremfya |
| Ucb, INC. | $329.04 | 2024-2025 | Bimzelx |
| Novartis Pharmaceuticals Corporation | $264.71 | 2025 | |
| Sun Pharmaceutical Industries INC. | $188.77 | 2024-2025 | |
| Organon LLC | $159.79 | 2025 | Vtama |
| Lilly USA, LLC | $67.66 | 2024-2025 | Ebglyss, Taltz |
| Regeneron Healthcare Solutions, INC. | $65.69 | 2025 | Dupixent |
| Ani Pharmaceuticals, INC. | $51.75 | 2025 | Purified Cortrophin Gel |
| Incyte Corporation | $50.92 | 2024-2025 | Opzelura |
| Abbvie INC. | $43.30 | 2024-2025 | |
| Arcutis Biotherapeutics, INC. | $41.08 | 2025 | Zoryve |
| Molnlycke Health Care US, LLC | $35.68 | 2025 | Mepitel, Mepilex Ag, Mepiform |
| Leo Pharma INC. | $29.91 | 2025 | Adbry |
| Amgen INC. | $28.50 | 2025 | Otezla |
| Pfizer INC. | $16.66 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caitlin Dumm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.